New York State Common Retirement Fund Sells 2,330 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

New York State Common Retirement Fund cut its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 11.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,551 shares of the medical instruments supplier's stock after selling 2,330 shares during the period. New York State Common Retirement Fund owned approximately 0.09% of Mettler-Toledo International worth $27,821,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Family Firm Inc. bought a new position in shares of Mettler-Toledo International during the second quarter worth $25,000. Blue Trust Inc. grew its stake in Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier's stock valued at $34,000 after acquiring an additional 17 shares during the period. Rothschild Investment LLC bought a new stake in shares of Mettler-Toledo International in the second quarter worth about $42,000. Itau Unibanco Holding S.A. acquired a new stake in shares of Mettler-Toledo International during the second quarter worth about $42,000. Finally, Crewe Advisors LLC lifted its holdings in shares of Mettler-Toledo International by 244.4% during the 2nd quarter. Crewe Advisors LLC now owns 31 shares of the medical instruments supplier's stock valued at $43,000 after purchasing an additional 22 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have commented on MTD shares. Stifel Nicolaus raised their target price on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a "buy" rating in a report on Monday, August 5th. StockNews.com raised shares of Mettler-Toledo International from a "hold" rating to a "buy" rating in a research report on Thursday, July 11th. The Goldman Sachs Group increased their target price on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a "neutral" rating in a report on Tuesday, July 9th. JPMorgan Chase & Co. boosted their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a "neutral" rating in a report on Monday, August 5th. Finally, Wells Fargo & Company initiated coverage on Mettler-Toledo International in a report on Tuesday, August 27th. They set an "equal weight" rating and a $1,400.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Mettler-Toledo International currently has an average rating of "Hold" and a consensus price target of $1,363.75.

Insider Transactions at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 250 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the transaction, the chief financial officer now owns 4,914 shares in the company, valued at approximately $6,884,514. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Mettler-Toledo International news, insider Christian Magloth sold 1,000 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the transaction, the insider now owns 734 shares in the company, valued at $1,044,459.98. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Shawn Vadala sold 250 shares of the firm's stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the transaction, the chief financial officer now directly owns 4,914 shares in the company, valued at $6,884,514. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company's stock.

Mettler-Toledo International Price Performance

MTD stock traded up $21.93 during mid-day trading on Monday, reaching $1,364.02. The company had a trading volume of 117,713 shares, compared to its average volume of 132,462. The company has a market capitalization of $28.94 billion, a price-to-earnings ratio of 37.53, a PEG ratio of 3.78 and a beta of 1.16. Mettler-Toledo International Inc. has a 52 week low of $953.28 and a 52 week high of $1,546.93. The stock has a 50 day simple moving average of $1,402.22 and a two-hundred day simple moving average of $1,398.02.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, topping the consensus estimate of $9.00 by $0.65. The business had revenue of $946.75 million during the quarter, compared to the consensus estimate of $929.13 million. Mettler-Toledo International had a net margin of 20.95% and a negative return on equity of 575.61%. Mettler-Toledo International's revenue was down 3.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $10.19 EPS. On average, equities analysts predict that Mettler-Toledo International Inc. will post 40.34 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.